Literature DB >> 30153588

Unusual ent-atisane type diterpenoids with 2-oxopropyl skeleton from the roots of Euphorbia ebracteolata and their antiviral activity against human rhinovirus 3 and enterovirus 71.

Bo Wang1, Yunlong Wei1, Xinyu Zhao1, Xiangge Tian1, Jing Ning1, Baojing Zhang1, Sa Deng1, Dawei Li2, Xiaochi Ma3, Chao Wang4.   

Abstract

Two novel ent-atisane type diterpenoids possessing the extra unusal 2-oxopropyl moiety (1 and 2) and four known analogues have been isolated from the roots of Euphorbia ebracteolata. The structures and absolute configurations of these compounds were determined by extensive spectroscopic data analysis, including 2D NMR, single-crystal X-ray crystallography, 13C NMR calculation, and electronic circular dichroism spectra calculation. Compounds 1 and 2 are the first examples of natural products with ent-atisane type diterpenoids possessing 2-oxopropyl skeleton. Compounds 2, 3, 5, and 6 show antiviral activities against human rhinovirus 3, with IC50 values of 25.27-90.35 μM. Compounds 5 and 6 showed moderate antiviral activities against EV71 at a concentration of 100 μM.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atisane; Diterpenoids; EV71; Euphorbia ebracteolata; HRV3

Mesh:

Substances:

Year:  2018        PMID: 30153588     DOI: 10.1016/j.bioorg.2018.08.029

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

Review 1.  Antimicrobial Diterpenes: Recent Development From Natural Sources.

Authors:  Poushali Saha; Fahad Imtiaz Rahman; Fahad Hussain; S M Abdur Rahman; M Mukhlesur Rahman
Journal:  Front Pharmacol       Date:  2022-02-28       Impact factor: 5.810

2.  In vitro antiviral activity of peptide-rich extracts from seven Nigerian plants against three non-polio enterovirus species C serotypes.

Authors:  Omonike O Ogbole; Toluwanimi E Akinleye; Abraham O Nkumah; Aminat O Awogun; Alfred F Attah; Moses O Adewumi; Adekunle J Adeniji
Journal:  Virol J       Date:  2021-08-04       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.